Hongbo Lu's Net Worth
$7.63 Million
Who is Hongbo Lu?
Hongbo Lu has an estimated net worth of $7.63 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, Turning Point Therapeutics, Inc., and Terns Pharmaceuticals, Inc..
SEC CIK
Hongbo Lu's CIK is 0001767584
Past Insider Trading and Trends
2022 was Hongbo Lu's most active year for acquiring shares with 7 total transactions. Hongbo Lu's most active month to acquire stocks was the month of March. 2019 was Hongbo Lu's most active year for disposing of shares, totalling 4 transactions. Hongbo Lu's most active month to dispose stocks was the month of March. 2022 saw Hongbo Lu paying a total of $18,270,089.40 for 5,514,859 shares, this is the most they've acquired in one year. In 2019 Hongbo Lu cashed out on 6,431,387 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AVEDRO INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Turning Point Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.73M |
$18.00 |
—
| 1.73M |
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Terns Pharmaceuticals, Inc. (TERN) Snapshot price: $5.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +21.18% | 758.62K |
$7.25 | $5,499,995.00 | 4.34M |
Dec 23
| |||
Form 4
| +20.12% | 600K |
$3.60 | $2,160,000.00 | 3.58M |
Sep 7
| |||
Form 4
| +734.35% | 2.62M |
$2.66 | $6,980,244.40 | 2.98M |
Aug 12 - Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.78% | 3K |
$27.66 | $82,990.00 | 33.68K |
Mar 18 - Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||